Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 6/2009

Open Access 01-06-2009 | Head and Neck

Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review

Authors: Lisette van der Molen, Maya A. van Rossum, Lori M. Burkhead, Ludi E. Smeele, Frans J. M. Hilgers

Published in: European Archives of Oto-Rhino-Laryngology | Issue 6/2009

Login to get access

Abstract

Organ preservation with radiotherapy and concomitant chemotherapy has become an accepted treatment modality in advanced head and neck cancer. Unfortunately, organ preservation is not synonymous with function preservation. The aim of this review was to systematically assess the effects of the disease and chemoradiotherapy (CRT) on functions such as swallowing, mouth opening, nutrition, pain and quality of life in patients with head and neck cancer. Another aim was to search for (evidence-based) techniques or strategies known to alleviate or rehabilitate the loss of function(s) associated with CRT. Two databases were searched (time period, January 1997 to August 2007) for the terms head and neck cancer, chemotherapy or cisplatin and radiotherapy, and the functional outcomes swallowing, trismus, nutrition, pain and quality of life or a variation of those words. In total, 15 relevant articles were identified that met the inclusion criteria. The majority of the studies that met the criteria focused on the outcomes swallowing, quality of life, and nutrition. Two studies reported on the outcome pain, but no paper reported on the outcome trismus. Only two papers mentioned rehabilitation options, but specific information was lacking. Further long-term prospective research is essential, not only to determine the function impairment caused by the tumor and CRT, but also to assess the effects of known and newly developed rehabilitation measures. Therefore, in September 2006, the Netherlands Cancer Institute started a randomised clinical trial (RCT): Prevention of trismus, swallowing and speech problems in patients treated with chemoradiotherapy for advanced head and neck cancer. This systematic review was carried out to collect the baseline information for the future outcomes of this RCT.
Footnotes
1
A complete list of the papers retrieved from the databases is available from the corresponding author. The fifteen papers ‘surviving’ the predefined ‘quality’ criteria are listed in bold and the papers collected after the reviewed period are listed bold and italic.
 
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
2.
go back to reference World Health Organisation (2005).WHO Cancer Control Strategy 2005. Global programming note 2005–2007 CFRMAEO (2 A.D.). Retrieved in January 2007 World Health Organisation (2005).WHO Cancer Control Strategy 2005. Global programming note 2005–2007 CFRMAEO (2 A.D.). Retrieved in January 2007
3.
go back to reference Nederlands werkgroep hoofd-halstumoren (Dutch Cooperative Group on Head and Neck Cancer) (2005) Richtlijn Mondholte en orofarynxcarcinoom. Van Zuiden, Alphen a/d Rijn, pp 173–199 Nederlands werkgroep hoofd-halstumoren (Dutch Cooperative Group on Head and Neck Cancer) (2005) Richtlijn Mondholte en orofarynxcarcinoom. Van Zuiden, Alphen a/d Rijn, pp 173–199
4.
go back to reference Copper MP, Tan IB, Oppelaar H, Ruevekamp MC, Stewart FA (2003) Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129:709–711PubMedCrossRef Copper MP, Tan IB, Oppelaar H, Ruevekamp MC, Stewart FA (2003) Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129:709–711PubMedCrossRef
5.
go back to reference Ward EC, van As-Brooks CJ (2007) Head and neck cancer, treatment, rehabilitation, and outcomes. Plural Publishing, San Diego Ward EC, van As-Brooks CJ (2007) Head and neck cancer, treatment, rehabilitation, and outcomes. Plural Publishing, San Diego
6.
go back to reference Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE, Rademaker A, Logemann JA (2003) Swallowing dysfunction—preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 57:1219–1230PubMed Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE, Rademaker A, Logemann JA (2003) Swallowing dysfunction—preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 57:1219–1230PubMed
7.
go back to reference Lee WT, Akst LM, Adelstein DJ, Saxton JP, Wood BG, Strome M, Butler RS, Esclamado RM (2006) Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiotherapy. Head Neck 28:808–812PubMedCrossRef Lee WT, Akst LM, Adelstein DJ, Saxton JP, Wood BG, Strome M, Butler RS, Esclamado RM (2006) Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiotherapy. Head Neck 28:808–812PubMedCrossRef
8.
go back to reference Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J (2006) Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiotherapy: a new treatment paradigm. J Clin Oncol 24:593–598PubMedCrossRef Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J (2006) Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiotherapy: a new treatment paradigm. J Clin Oncol 24:593–598PubMedCrossRef
9.
go back to reference Allal AS, Nicoucar K, Mach N, Dulguerov P (2003) Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck 25:833–839PubMedCrossRef Allal AS, Nicoucar K, Mach N, Dulguerov P (2003) Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck 25:833–839PubMedCrossRef
10.
go back to reference Smith RV, Kotz T, Beitler JJ, Wadler S (2000) Long-term swallowing problems after organ preservation therapy with concomitant radiotherapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg 126:384–389PubMed Smith RV, Kotz T, Beitler JJ, Wadler S (2000) Long-term swallowing problems after organ preservation therapy with concomitant radiotherapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg 126:384–389PubMed
11.
go back to reference Kotz T, Abraham S, Beitler JJ, Wadler S, Smith RV (1999) Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg 125:410–413PubMed Kotz T, Abraham S, Beitler JJ, Wadler S, Smith RV (1999) Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg 125:410–413PubMed
12.
go back to reference Murry T, Madasu R, Martin A, Robbins KT (1998) Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiotherapy for organ preservation in patients with advanced head and neck cancer. Head Neck 20:31–37PubMedCrossRef Murry T, Madasu R, Martin A, Robbins KT (1998) Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiotherapy for organ preservation in patients with advanced head and neck cancer. Head Neck 20:31–37PubMedCrossRef
13.
go back to reference Kotz T, Costello R, Li Y, Posner MR (2004) Swallowing dysfunction after chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Head Neck 26:365–372PubMedCrossRef Kotz T, Costello R, Li Y, Posner MR (2004) Swallowing dysfunction after chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Head Neck 26:365–372PubMedCrossRef
14.
go back to reference Shiley SG, Hargunani CA, Skoner JM, Holland JM, Wax MK (2006) Swallowing function after chemoradiotherapy for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 134:455–459PubMedCrossRef Shiley SG, Hargunani CA, Skoner JM, Holland JM, Wax MK (2006) Swallowing function after chemoradiotherapy for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 134:455–459PubMedCrossRef
15.
go back to reference Gaziano JE (2002) Evaluation and management of oropharyngeal Dysphagia in head and neck cancer. Cancer Control 9:400–409PubMed Gaziano JE (2002) Evaluation and management of oropharyngeal Dysphagia in head and neck cancer. Cancer Control 9:400–409PubMed
16.
go back to reference Rankin KV (2000) Oral health in cancer therapy: evaluating and preventing oral complications. Dent Today 19:60–65PubMed Rankin KV (2000) Oral health in cancer therapy: evaluating and preventing oral complications. Dent Today 19:60–65PubMed
17.
go back to reference Lazarus CL (1993) Effects of radiotherapy therapy and voluntary maneuvers on swallow functioning in head and neck cancer patients. Clin Commun Disord 3:11–20PubMed Lazarus CL (1993) Effects of radiotherapy therapy and voluntary maneuvers on swallow functioning in head and neck cancer patients. Clin Commun Disord 3:11–20PubMed
18.
go back to reference Dijkstra PU, Kalk WW, Roodenburg JL (2004) Trismus in head and neck oncology: a systematic review. Oral Oncol 40:879–889PubMedCrossRef Dijkstra PU, Kalk WW, Roodenburg JL (2004) Trismus in head and neck oncology: a systematic review. Oral Oncol 40:879–889PubMedCrossRef
19.
go back to reference Logemann JA (1998) Evaluation and treatment of swallowing disorders, 2nd edn. Pro-Ed, Austin, TX Logemann JA (1998) Evaluation and treatment of swallowing disorders, 2nd edn. Pro-Ed, Austin, TX
20.
go back to reference Lazarus CL, Logemann JA, Rademaker A, Kahrilas PJ (2002) Effects of voluntary maneuvres on tongue base function for swallowing. Folia Phoniatr Logop 54:171–176PubMedCrossRef Lazarus CL, Logemann JA, Rademaker A, Kahrilas PJ (2002) Effects of voluntary maneuvres on tongue base function for swallowing. Folia Phoniatr Logop 54:171–176PubMedCrossRef
21.
go back to reference Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA (1997) Super-supraglottic swallow in irradiated head and neck cancer patients. Head Neck 19:535–540PubMedCrossRef Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA (1997) Super-supraglottic swallow in irradiated head and neck cancer patients. Head Neck 19:535–540PubMedCrossRef
22.
go back to reference Abdel-Wahab M, Abitbol A, Lewin A, Troner M, Hamilton K, Markoe A (2005) Quality-of-life assessment after hyperfractionated radiotherapy therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma. Am J Clin Oncol 28:359–366PubMedCrossRef Abdel-Wahab M, Abitbol A, Lewin A, Troner M, Hamilton K, Markoe A (2005) Quality-of-life assessment after hyperfractionated radiotherapy therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma. Am J Clin Oncol 28:359–366PubMedCrossRef
23.
go back to reference Ackerstaff AH, Tan IB, Rasch CR, Balm AJ, Keus RB, Schornagel JH, Hilgers FJ (2002) Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiotherapy (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 128:1185–1190PubMed Ackerstaff AH, Tan IB, Rasch CR, Balm AJ, Keus RB, Schornagel JH, Hilgers FJ (2002) Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiotherapy (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 128:1185–1190PubMed
24.
go back to reference Adelstein DJ, Saxton JP, Lavertu P, Rybicki LA, Esclamado RM, Wood BG, Strome M, Carroll MA (2002) Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiotherapy and concurrent chemotherapy. J Clin Oncol 20:1405–1410PubMedCrossRef Adelstein DJ, Saxton JP, Lavertu P, Rybicki LA, Esclamado RM, Wood BG, Strome M, Carroll MA (2002) Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiotherapy and concurrent chemotherapy. J Clin Oncol 20:1405–1410PubMedCrossRef
25.
go back to reference Akst LM, Chan J, Elson P, Saxton J, Strome M, Adelstein D (2004) Functional outcomes following chemoradiotherapy for head and neck cancer. Otolaryngol Head Neck Surg 131:950–957PubMedCrossRef Akst LM, Chan J, Elson P, Saxton J, Strome M, Adelstein D (2004) Functional outcomes following chemoradiotherapy for head and neck cancer. Otolaryngol Head Neck Surg 131:950–957PubMedCrossRef
26.
go back to reference Albuquerque K, Cirrone J, Aziz H, Har-El G, Sundaram K, Dipillo F, Fulton L, Aral I, Schulsinger A, Rotman M (2001) Quality of life with functional pharyngeal preservation in advanced carcinomas of the base tongue complex using an integrated trimodality approach. Am J Clin Oncol 24:623–627PubMedCrossRef Albuquerque K, Cirrone J, Aziz H, Har-El G, Sundaram K, Dipillo F, Fulton L, Aral I, Schulsinger A, Rotman M (2001) Quality of life with functional pharyngeal preservation in advanced carcinomas of the base tongue complex using an integrated trimodality approach. Am J Clin Oncol 24:623–627PubMedCrossRef
27.
go back to reference Arraras Urdaniz JI, Arias de la Vega F, Manterola Burgaleta A, Vera Garcia R, Martinez Aguillo M, Salgado Pascual E, Martinez Lopez E (2005) Quality of life in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Comparison of two protocols using the EORTC questionnaires (QLQ-C30, H and N35). Clin Transl Oncol 7:398–403PubMedCrossRef Arraras Urdaniz JI, Arias de la Vega F, Manterola Burgaleta A, Vera Garcia R, Martinez Aguillo M, Salgado Pascual E, Martinez Lopez E (2005) Quality of life in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Comparison of two protocols using the EORTC questionnaires (QLQ-C30, H and N35). Clin Transl Oncol 7:398–403PubMedCrossRef
28.
go back to reference Balm AJ, Rasch CR, Schornagel JH, Hilgers FJ, Keus RB, Schultze-Kool L, Ackerstaff AH, Busschers W, Tan IB (2004) High-dose superselective intra-arterial cisplatin and concomitant radiotherapy (RADPLAT) for advanced head and neck cancer. Head Neck 26:485–493PubMedCrossRef Balm AJ, Rasch CR, Schornagel JH, Hilgers FJ, Keus RB, Schultze-Kool L, Ackerstaff AH, Busschers W, Tan IB (2004) High-dose superselective intra-arterial cisplatin and concomitant radiotherapy (RADPLAT) for advanced head and neck cancer. Head Neck 26:485–493PubMedCrossRef
29.
go back to reference Barasch A, Safford M, Eisenberg E (1998) Oral cancer and oral effects of anticancer therapy. Mt Sinai J Med 65:370–377PubMed Barasch A, Safford M, Eisenberg E (1998) Oral cancer and oral effects of anticancer therapy. Mt Sinai J Med 65:370–377PubMed
30.
go back to reference Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, Biorklund A, de Leeuw JR, Fayers PM, Jannert M, Westin T, Kaasa S (1999) Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 17:1008–1019PubMed Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, Biorklund A, de Leeuw JR, Fayers PM, Jannert M, Westin T, Kaasa S (1999) Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 17:1008–1019PubMed
31.
go back to reference Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Biorklund A, Jannert M, Westin T, Kaasa S (2001) A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope 111:1440–1452PubMedCrossRef Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Biorklund A, Jannert M, Westin T, Kaasa S (2001) A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope 111:1440–1452PubMedCrossRef
32.
go back to reference Carrara-de Angelis E, Feher O, Barros AP, Nishimoto IN, Kowalski LP (2003) Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg 129:733–738PubMedCrossRef Carrara-de Angelis E, Feher O, Barros AP, Nishimoto IN, Kowalski LP (2003) Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg 129:733–738PubMedCrossRef
33.
go back to reference Cengiz M, Ozyar E, Esassolak M, Altun M, Akmansu M, Sen M, Uzel O, Yavuz A, Dalmaz G, Uzal C, Hicsonmez A, Sarihan S, Kaplan B, Atasoy BM, Ulutin C, Abacioglu U, Demiral AN, Hayran M (2005) Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys 63:1347–1353PubMedCrossRef Cengiz M, Ozyar E, Esassolak M, Altun M, Akmansu M, Sen M, Uzel O, Yavuz A, Dalmaz G, Uzal C, Hicsonmez A, Sarihan S, Kaplan B, Atasoy BM, Ulutin C, Abacioglu U, Demiral AN, Hayran M (2005) Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys 63:1347–1353PubMedCrossRef
34.
go back to reference Cohen EE, Haraf DJ, List MA, Kocherginsky M, Mittal BB, Rosen F, Brockstein B, Williams R, Witt ME, Stenson KM, Kies MS, Vokes EE (2006) High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial. J Clin Oncol 24:3438–3444PubMedCrossRef Cohen EE, Haraf DJ, List MA, Kocherginsky M, Mittal BB, Rosen F, Brockstein B, Williams R, Witt ME, Stenson KM, Kies MS, Vokes EE (2006) High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial. J Clin Oncol 24:3438–3444PubMedCrossRef
35.
go back to reference El Deiry M, Funk GF, Nalwa S, Karnell LH, Smith RB, Buatti JM, Hoffman HT, Clamon GH, Graham SM, Trask DK, Dornfeld KJ, Yao M (2005) Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg 131:879–885PubMedCrossRef El Deiry M, Funk GF, Nalwa S, Karnell LH, Smith RB, Buatti JM, Hoffman HT, Clamon GH, Graham SM, Trask DK, Dornfeld KJ, Yao M (2005) Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg 131:879–885PubMedCrossRef
36.
go back to reference Epstein JB, Beaumont JL, Gwede CK, Murphy B, Garden AS, Meredith R, Le QT, Brizel D, Isitt J, Cella D (2007) Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer 109:1914–1922PubMedCrossRef Epstein JB, Beaumont JL, Gwede CK, Murphy B, Garden AS, Meredith R, Le QT, Brizel D, Isitt J, Cella D (2007) Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer 109:1914–1922PubMedCrossRef
37.
go back to reference Fang FM, Tsai WL, Chien CY, Chiu HC, Wang CJ, Chen HC, Hsiung CY (2005) Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiotherapy. Oncology 68:405–413PubMedCrossRef Fang FM, Tsai WL, Chien CY, Chiu HC, Wang CJ, Chen HC, Hsiung CY (2005) Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiotherapy. Oncology 68:405–413PubMedCrossRef
38.
go back to reference Franzmann EJ, Lundy DS, Abitbol AA, Goodwin WJ (2006) Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiotherapy for advanced head and neck cancer. Head Neck 28:663–670PubMedCrossRef Franzmann EJ, Lundy DS, Abitbol AA, Goodwin WJ (2006) Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiotherapy for advanced head and neck cancer. Head Neck 28:663–670PubMedCrossRef
39.
go back to reference Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A, Tsien C, Bradford CR, Chepeha DB, Hogikyan ND, Prince ME, Teknos TN, Wolf GT (2005) Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 63:1395–1399PubMedCrossRef Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A, Tsien C, Bradford CR, Chepeha DB, Hogikyan ND, Prince ME, Teknos TN, Wolf GT (2005) Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 63:1395–1399PubMedCrossRef
40.
go back to reference Goguen LA, Posner MR, Norris CM, Tishler RB, Wirth LJ, Annino DJ, Gagne A, Sullivan CA, Sammartino DE, Haddad RI (2006) Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 134:916–922PubMedCrossRef Goguen LA, Posner MR, Norris CM, Tishler RB, Wirth LJ, Annino DJ, Gagne A, Sullivan CA, Sammartino DE, Haddad RI (2006) Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 134:916–922PubMedCrossRef
41.
go back to reference Gourin CG, McAfee WJ, Neyman KM, Howington JW, Podolsky RH, Terris DJ (2005) Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck. Laryngoscope 115:1371–1375PubMedCrossRef Gourin CG, McAfee WJ, Neyman KM, Howington JW, Podolsky RH, Terris DJ (2005) Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck. Laryngoscope 115:1371–1375PubMedCrossRef
42.
go back to reference Graner DE, Foote RL, Kasperbauer JL, Stoeckel RE, Okuno SH, Olsen KD, Sabri AN, Maragos NE, Cha SS, Sargent DJ, Strome SE (2003) Swallow function in patients before and after intra-arterial chemoradiotherapy. Laryngoscope 113:573–579PubMedCrossRef Graner DE, Foote RL, Kasperbauer JL, Stoeckel RE, Okuno SH, Olsen KD, Sabri AN, Maragos NE, Cha SS, Sargent DJ, Strome SE (2003) Swallow function in patients before and after intra-arterial chemoradiotherapy. Laryngoscope 113:573–579PubMedCrossRef
43.
go back to reference Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R (2005) Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol 28:371–378PubMedCrossRef Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R (2005) Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol 28:371–378PubMedCrossRef
44.
go back to reference Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, Suen JY (2004) Quality of life for patients following total laryngectomy vs chemoradiotherapy for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130:875–879PubMedCrossRef Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, Suen JY (2004) Quality of life for patients following total laryngectomy vs chemoradiotherapy for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130:875–879PubMedCrossRef
45.
go back to reference Hillman RE, Walsh MJ, Wolf GT, Fisher SG, Hong WK (1998) Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II—laryngectomy rehabilitation: the state of the art in the VA System. Research speech-language pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl 172:1–27PubMed Hillman RE, Walsh MJ, Wolf GT, Fisher SG, Hong WK (1998) Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II—laryngectomy rehabilitation: the state of the art in the VA System. Research speech-language pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl 172:1–27PubMed
46.
go back to reference Jereczek-Fossa BA, Santoro L, Alterio D, Franchi B, Fiore MR, Fossati P, Kowalczyk A, Canino P, Ansarin M, Orecchia R (2007) Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys 68:403–415PubMed Jereczek-Fossa BA, Santoro L, Alterio D, Franchi B, Fiore MR, Fossati P, Kowalczyk A, Canino P, Ansarin M, Orecchia R (2007) Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys 68:403–415PubMed
47.
go back to reference Kulbersh BD, Rosenthal EL, McGrew BM, Duncan RD, McColloch NL, Carroll WR, Magnuson JS (2006) Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope 116:883–886PubMedCrossRef Kulbersh BD, Rosenthal EL, McGrew BM, Duncan RD, McColloch NL, Carroll WR, Magnuson JS (2006) Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope 116:883–886PubMedCrossRef
48.
go back to reference Lazarus CL, Logemann JA, Pauloski BR, Rademaker AW, Larson CR, Mittal BB, Pierce M (2000) Swallowing and tongue function following treatment for oral and oropharyngeal cancer. J Speech Lang Hear Res 43:1011–1023PubMed Lazarus CL, Logemann JA, Pauloski BR, Rademaker AW, Larson CR, Mittal BB, Pierce M (2000) Swallowing and tongue function following treatment for oral and oropharyngeal cancer. J Speech Lang Hear Res 43:1011–1023PubMed
49.
go back to reference Lee JS, Iranmanesh A, Schmidt BL, Fischbein NJ, McKenna SJ (2005) Limited oral opening in a 43-year-old man. J Oral Maxillofac Surg 63:103–108PubMedCrossRef Lee JS, Iranmanesh A, Schmidt BL, Fischbein NJ, McKenna SJ (2005) Limited oral opening in a 43-year-old man. J Oral Maxillofac Surg 63:103–108PubMedCrossRef
50.
go back to reference List MA, Mumby P, Haraf D, Siston A, Mick R, MacCracken E, Vokes E (1997) Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 6:274–284PubMedCrossRef List MA, Mumby P, Haraf D, Siston A, Mick R, MacCracken E, Vokes E (1997) Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 6:274–284PubMedCrossRef
51.
go back to reference List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K, Vokes EE (1999) Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 17:1020–1028PubMed List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K, Vokes EE (1999) Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 17:1020–1028PubMed
52.
go back to reference Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, MacCracken E, Haraf DJ, Vokes EE, Newman LA, Liu D (2006) Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiotherapy. Head Neck 28:64–73PubMedCrossRef Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, MacCracken E, Haraf DJ, Vokes EE, Newman LA, Liu D (2006) Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiotherapy. Head Neck 28:64–73PubMedCrossRef
53.
go back to reference LoTempio MM, Wang KH, Sadeghi A, Delacure MD, Juillard GF, Wang MB (2005) Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiotherapy vs. total laryngectomy. Otolaryngol Head Neck Surg 132:948–953PubMedCrossRef LoTempio MM, Wang KH, Sadeghi A, Delacure MD, Juillard GF, Wang MB (2005) Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiotherapy vs. total laryngectomy. Otolaryngol Head Neck Surg 132:948–953PubMedCrossRef
54.
go back to reference Magne N, Marcy PY, Chamorey E, Guardiola E, Pivot X, Schneider M, Demard F, Bensadoun RJ (2001) Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: a long-term quality of life analysis. Head Neck 23:678–682PubMedCrossRef Magne N, Marcy PY, Chamorey E, Guardiola E, Pivot X, Schneider M, Demard F, Bensadoun RJ (2001) Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: a long-term quality of life analysis. Head Neck 23:678–682PubMedCrossRef
55.
go back to reference Major MS, Bumpous JM, Flynn MB, Schill K (2001) Quality of life after treatment for advanced laryngeal and hypopharyngeal cancer. Laryngoscope 111:1379–1382PubMedCrossRef Major MS, Bumpous JM, Flynn MB, Schill K (2001) Quality of life after treatment for advanced laryngeal and hypopharyngeal cancer. Laryngoscope 111:1379–1382PubMedCrossRef
56.
go back to reference Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE (2004) Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer. Head Neck 26:561–572PubMedCrossRef Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE (2004) Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer. Head Neck 26:561–572PubMedCrossRef
57.
go back to reference Marcy PY, Magne N, Bensadoun RJ, Bleuse A, Falewee MN, Viot M, Bruneton JN (2000) Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer: optimization of therapy. Support Care Cancer 8:410–413PubMedCrossRef Marcy PY, Magne N, Bensadoun RJ, Bleuse A, Falewee MN, Viot M, Bruneton JN (2000) Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer: optimization of therapy. Support Care Cancer 8:410–413PubMedCrossRef
58.
go back to reference Mowry SE, LoTempio MM, Sadeghi A, Wang KH, Wang MB (2006) Quality of life outcomes in laryngeal and oropharyngeal cancer patients after chemoradiotherapy. Otolaryngol Head Neck Surg 135:565–570PubMedCrossRef Mowry SE, LoTempio MM, Sadeghi A, Wang KH, Wang MB (2006) Quality of life outcomes in laryngeal and oropharyngeal cancer patients after chemoradiotherapy. Otolaryngol Head Neck Surg 135:565–570PubMedCrossRef
59.
go back to reference Newman LA, Vieira F, Schwiezer V, Samant S, Murry T, Woodson G, Kumar P, Robbins KT (1998) Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 124:589–592PubMed Newman LA, Vieira F, Schwiezer V, Samant S, Murry T, Woodson G, Kumar P, Robbins KT (1998) Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 124:589–592PubMed
60.
go back to reference Newman LA, Robbins KT, Logemann JA, Rademaker AW, Lazarus CL, Hamner A, Tusant S, Huang CF (2002) Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiotherapy. Head Neck 24:68–77PubMedCrossRef Newman LA, Robbins KT, Logemann JA, Rademaker AW, Lazarus CL, Hamner A, Tusant S, Huang CF (2002) Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiotherapy. Head Neck 24:68–77PubMedCrossRef
61.
go back to reference Nguyen NP, Sallah S, Karlsson U, Antoine JE (2002) Combined chemotherapy and radiotherapy therapy for head and neck malignancies: quality of life issues. Cancer 94:1131–1141PubMedCrossRef Nguyen NP, Sallah S, Karlsson U, Antoine JE (2002) Combined chemotherapy and radiotherapy therapy for head and neck malignancies: quality of life issues. Cancer 94:1131–1141PubMedCrossRef
62.
go back to reference Nguyen NP, Levinson B, Dutta S, Karlsson U, Kelly KC, Dowell J, Ludin A, Sallah S (2003) Amifostine and curative intent chemoradiation for compromised cancer patients. Anticancer Res 23:1649–1656PubMed Nguyen NP, Levinson B, Dutta S, Karlsson U, Kelly KC, Dowell J, Ludin A, Sallah S (2003) Amifostine and curative intent chemoradiation for compromised cancer patients. Anticancer Res 23:1649–1656PubMed
63.
go back to reference Nguyen NP, Moltz CC, Frank C, Vos P, Smith HJ, Karlsson U, Dutta S, Midyett FA, Barloon J, Sallah S (2004) Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 15:383–388PubMedCrossRef Nguyen NP, Moltz CC, Frank C, Vos P, Smith HJ, Karlsson U, Dutta S, Midyett FA, Barloon J, Sallah S (2004) Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 15:383–388PubMedCrossRef
64.
go back to reference Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Karlsson U, Dutta S, Midyett A, Barloon J, Sallah S (2005) Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 61:772–778PubMed Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Karlsson U, Dutta S, Midyett A, Barloon J, Sallah S (2005) Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 61:772–778PubMed
65.
go back to reference Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Bhamidipati PV, Karlsson U, Nguyen PD, Alfieri A, Nguyen LM, Lemanski C, Chan W, Rose S, Sallah S (2006) Aspiration rate following chemoradiotherapy for head and neck cancer: an underreported occurrence. Radiother Oncol 80:302–306PubMedCrossRef Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Bhamidipati PV, Karlsson U, Nguyen PD, Alfieri A, Nguyen LM, Lemanski C, Chan W, Rose S, Sallah S (2006) Aspiration rate following chemoradiotherapy for head and neck cancer: an underreported occurrence. Radiother Oncol 80:302–306PubMedCrossRef
66.
go back to reference Nguyen NP, Moltz CC, Frank C, Karlsson U, Nguyen PD, Vos P, Smith HJ, Dutta S, Nguyen LM, Lemanski C, Chan W, Sallah S (2006) Dysphagia severity following chemoradiotherapy and postoperative radiotherapy for head and neck cancer. Eur J Radiol 59:453–459PubMedCrossRef Nguyen NP, Moltz CC, Frank C, Karlsson U, Nguyen PD, Vos P, Smith HJ, Dutta S, Nguyen LM, Lemanski C, Chan W, Sallah S (2006) Dysphagia severity following chemoradiotherapy and postoperative radiotherapy for head and neck cancer. Eur J Radiol 59:453–459PubMedCrossRef
67.
go back to reference Nguyen NP, Moltz CC, Frank C, Vos P, Millar C, Smith HJ, Lee H, Karlsson U, Nguyen PD, Martinez T, Nguyen LM, Sallah S (2007) Aspiration rate following nonsurgical therapy for laryngeal cancer. ORL J Otorhinolaryngol Relat Spec 69:116–120PubMed Nguyen NP, Moltz CC, Frank C, Vos P, Millar C, Smith HJ, Lee H, Karlsson U, Nguyen PD, Martinez T, Nguyen LM, Sallah S (2007) Aspiration rate following nonsurgical therapy for laryngeal cancer. ORL J Otorhinolaryngol Relat Spec 69:116–120PubMed
68.
go back to reference Nguyen NP, Vos P, Smith HJ, Nguyen PD, Alfieri A, Karlsson U, Dutta S, Lemanski C, Nguyen LM, Sallah S (2007) Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol 28:3–8PubMedCrossRef Nguyen NP, Vos P, Smith HJ, Nguyen PD, Alfieri A, Karlsson U, Dutta S, Lemanski C, Nguyen LM, Sallah S (2007) Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol 28:3–8PubMedCrossRef
69.
go back to reference Oates JE, Clark JR, Read J, Reeves N, Gao K, Jackson M, Boyer M, O’brien CJ (2007) Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 133:533–540PubMedCrossRef Oates JE, Clark JR, Read J, Reeves N, Gao K, Jackson M, Boyer M, O’brien CJ (2007) Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 133:533–540PubMedCrossRef
70.
go back to reference Ohrn KE, Sjoden PO, Wahlin YB, Elf M (2001) Oral health and quality of life among patients with head and neck cancer or haematological malignancies. Support Care Cancer 9:528–538PubMedCrossRef Ohrn KE, Sjoden PO, Wahlin YB, Elf M (2001) Oral health and quality of life among patients with head and neck cancer or haematological malignancies. Support Care Cancer 9:528–538PubMedCrossRef
71.
go back to reference Ozyar E, Cengiz M, Gurkaynak M, Atahan IL (2005) Trismus as a presenting symptom in nasopharyngeal carcinoma. Radiother Oncol 77:73–76PubMedCrossRef Ozyar E, Cengiz M, Gurkaynak M, Atahan IL (2005) Trismus as a presenting symptom in nasopharyngeal carcinoma. Radiother Oncol 77:73–76PubMedCrossRef
72.
go back to reference Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A, MacCracken E, Gaziano J, Stachowiak L (2002) Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 24:555–565PubMedCrossRef Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A, MacCracken E, Gaziano J, Stachowiak L (2002) Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 24:555–565PubMedCrossRef
73.
go back to reference Pauloski BR, Rademaker AW, Logemann JA, Newman L, MacCracken E, Gaziano J, Stachowiak L (2006) Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. Head Neck 28:1069–1076PubMedCrossRef Pauloski BR, Rademaker AW, Logemann JA, Newman L, MacCracken E, Gaziano J, Stachowiak L (2006) Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. Head Neck 28:1069–1076PubMedCrossRef
74.
go back to reference Rademaker AW, Vonesh EF, Logemann JA, Pauloski BR, Liu D, Lazarus CL, Newman LA, May AH, MacCracken E, Gaziano J, Stachowiak L (2003) Eating ability in head and neck cancer patients after treatment with chemoradiotherapy: a 12-month follow-up study accounting for dropout. Head Neck 25:1034–1041PubMedCrossRef Rademaker AW, Vonesh EF, Logemann JA, Pauloski BR, Liu D, Lazarus CL, Newman LA, May AH, MacCracken E, Gaziano J, Stachowiak L (2003) Eating ability in head and neck cancer patients after treatment with chemoradiotherapy: a 12-month follow-up study accounting for dropout. Head Neck 25:1034–1041PubMedCrossRef
75.
go back to reference Rieger JM, Zalmanowitz JG, Wolfaardt JF (2006) Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature. Int J Oral Maxillofac Surg 35:581–587PubMedCrossRef Rieger JM, Zalmanowitz JG, Wolfaardt JF (2006) Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature. Int J Oral Maxillofac Surg 35:581–587PubMedCrossRef
76.
go back to reference Terrell JE, Fisher SG, Wolf GT (1998) Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg 124:964–971PubMed Terrell JE, Fisher SG, Wolf GT (1998) Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg 124:964–971PubMed
77.
go back to reference Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253–262PubMedCrossRef Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253–262PubMedCrossRef
78.
go back to reference van den Berg MG, Rasmussen-Conrad EL, Gwasara GM, Krabbe PF, Naber AH, Merkx MA (2006) A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr 25:765–772PubMedCrossRef van den Berg MG, Rasmussen-Conrad EL, Gwasara GM, Krabbe PF, Naber AH, Merkx MA (2006) A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr 25:765–772PubMedCrossRef
79.
go back to reference van den Broek GB, Balm AJ, van den Brekel MW, Hauptmann M, Schornagel JH, Rasch CR (2006) Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiotherapy for head and neck cancer. Radiother Oncol 81:143–150PubMedCrossRef van den Broek GB, Balm AJ, van den Brekel MW, Hauptmann M, Schornagel JH, Rasch CR (2006) Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiotherapy for head and neck cancer. Radiother Oncol 81:143–150PubMedCrossRef
80.
go back to reference Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, Brockstein BE, List MA, Fung BB, Portugal L, Mittal BB, Pelzer H, Weichselbaum RR, Haraf DJ (2003) Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21:320–326PubMedCrossRef Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, Brockstein BE, List MA, Fung BB, Portugal L, Mittal BB, Pelzer H, Weichselbaum RR, Haraf DJ (2003) Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21:320–326PubMedCrossRef
81.
go back to reference Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Wolf GT (2002) Objective assessment of swallowing dysfunction and aspiration after radiotherapy concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53:23–28PubMed Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Wolf GT (2002) Objective assessment of swallowing dysfunction and aspiration after radiotherapy concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53:23–28PubMed
82.
go back to reference Eisbruch A, Shewach DS, Bradford CR, Littles JF, Teknos TN, Chepeha DB, Marentette LJ, Terrell JE, Hogikyan ND, Dawson LA (2001) Radiotherapy concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. J Clin Oncol 19:792–799PubMed Eisbruch A, Shewach DS, Bradford CR, Littles JF, Teknos TN, Chepeha DB, Marentette LJ, Terrell JE, Hogikyan ND, Dawson LA (2001) Radiotherapy concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. J Clin Oncol 19:792–799PubMed
83.
go back to reference Moore A, McQuay A, Gray JAM (1995) Evidence-based everything, 12 edn. Bandolier Moore A, McQuay A, Gray JAM (1995) Evidence-based everything, 12 edn. Bandolier
84.
go back to reference Karnell MP, McCracken E (1994) A data base information storage and reporting system for videofluorographic oropharyngeal motility swallowing evaluation. Am J Speech Lang Pathol 8:54–60 Karnell MP, McCracken E (1994) A data base information storage and reporting system for videofluorographic oropharyngeal motility swallowing evaluation. Am J Speech Lang Pathol 8:54–60
85.
go back to reference Hassan SJ, Weymuller EA Jr (1993) Assessment of quality of life in head and neck cancer patients. Head Neck 15:485–496PubMedCrossRef Hassan SJ, Weymuller EA Jr (1993) Assessment of quality of life in head and neck cancer patients. Head Neck 15:485–496PubMedCrossRef
86.
go back to reference Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed
87.
go back to reference Bonomi AE, Cella DF, Hahn EA, Bjordal K, Sperner-Unterweger B, Gangeri L, Bergman B, Willems-Groot J, Hanquet P, Zittoun R (1996) Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system. Qual Life Res 5:309–320PubMedCrossRef Bonomi AE, Cella DF, Hahn EA, Bjordal K, Sperner-Unterweger B, Gangeri L, Bergman B, Willems-Groot J, Hanquet P, Zittoun R (1996) Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system. Qual Life Res 5:309–320PubMedCrossRef
88.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
89.
go back to reference Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50:441–450PubMedCrossRef Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50:441–450PubMedCrossRef
90.
go back to reference Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13:1249–1254PubMed Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13:1249–1254PubMed
91.
go back to reference Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Bredart A, Soderholm AL, Arraras JJ, Feine JS, Abendstein H, Morton RP, Pignon T, Huguenin P, Bottomly A, Kaasa S (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36:1796–1807PubMedCrossRef Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Bredart A, Soderholm AL, Arraras JJ, Feine JS, Abendstein H, Morton RP, Pignon T, Huguenin P, Bottomly A, Kaasa S (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36:1796–1807PubMedCrossRef
92.
go back to reference Sherman AC, Simonton S, Adams DC, Vural E, Owens B, Hanna E (2000) Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg 126:459–467PubMed Sherman AC, Simonton S, Adams DC, Vural E, Owens B, Hanna E (2000) Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg 126:459–467PubMed
93.
go back to reference Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiotherapy Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346PubMed Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiotherapy Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346PubMed
94.
go back to reference Kiebert G, Kaasa S (1993) Quality of Life in clinical trials: experience and perspective of the EORTC. J Natl Cancer Inst 85:365–376CrossRef Kiebert G, Kaasa S (1993) Quality of Life in clinical trials: experience and perspective of the EORTC. J Natl Cancer Inst 85:365–376CrossRef
95.
go back to reference List MA, Ritter-Sterr C, Lansky SB (1990) A performance status scale for head and neck cancer patients. Cancer 66:564–569PubMedCrossRef List MA, Ritter-Sterr C, Lansky SB (1990) A performance status scale for head and neck cancer patients. Cancer 66:564–569PubMedCrossRef
96.
go back to reference List MA, D’Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E (1996) The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer 77:2294–2301PubMedCrossRef List MA, D’Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E (1996) The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer 77:2294–2301PubMedCrossRef
97.
go back to reference Carroll WR, Locher JL, Canon CL, Bohannon IA, McColloch NL, Magnuson JS (2008) Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope 118(1):39–43PubMedCrossRef Carroll WR, Locher JL, Canon CL, Bohannon IA, McColloch NL, Magnuson JS (2008) Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope 118(1):39–43PubMedCrossRef
98.
go back to reference Hind JA, Nicosia MA, Roecker EB, Carnes ML, Robbins J (2001) Comparison of effortful and noneffortful swallows in healthy middle-aged and older adults. Arch Phys Med Rehabil 82:1661–1665PubMedCrossRef Hind JA, Nicosia MA, Roecker EB, Carnes ML, Robbins J (2001) Comparison of effortful and noneffortful swallows in healthy middle-aged and older adults. Arch Phys Med Rehabil 82:1661–1665PubMedCrossRef
99.
go back to reference Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA (1997) Speech and swallowing rehabilitation for head and neck cancer patients. Oncology (Williston Park) 11:651–6, 659 Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA (1997) Speech and swallowing rehabilitation for head and neck cancer patients. Oncology (Williston Park) 11:651–6, 659
100.
go back to reference Ohmae Y, Logemann JA, Kaiser P, Hanson DG, Kahrilas PJ (1996) Effects of two breath-holding maneuvers on oropharyngeal swallow. Ann Otol Rhinol Laryngol 105:123–131PubMed Ohmae Y, Logemann JA, Kaiser P, Hanson DG, Kahrilas PJ (1996) Effects of two breath-holding maneuvers on oropharyngeal swallow. Ann Otol Rhinol Laryngol 105:123–131PubMed
101.
go back to reference Robin DA, Goel A, Somodi LB, Luschei ES (1992) Tongue strength and endurance: relation to highly skilled movements. J Speech Hear Res 35:1239–1245PubMed Robin DA, Goel A, Somodi LB, Luschei ES (1992) Tongue strength and endurance: relation to highly skilled movements. J Speech Hear Res 35:1239–1245PubMed
102.
go back to reference Veis S, Logemann JA, Colangelo L (2000) Effects of three techniques on maximum posterior movement of the tongue base. Dysphagia 15:142–145PubMed Veis S, Logemann JA, Colangelo L (2000) Effects of three techniques on maximum posterior movement of the tongue base. Dysphagia 15:142–145PubMed
103.
go back to reference Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Gaziano J, Stachowiak L, Newman L, MacCracken E, Santa D, Mittal B (2008) Swallowing disorders in the first year after radiotherapy and chemoradiotherapy. Head Neck 30(2):148–158PubMedCrossRef Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Gaziano J, Stachowiak L, Newman L, MacCracken E, Santa D, Mittal B (2008) Swallowing disorders in the first year after radiotherapy and chemoradiotherapy. Head Neck 30(2):148–158PubMedCrossRef
104.
go back to reference Langerman A, MacCracken E, Kasza K, Haraf DJ, Vokes EE, Stenson KM (2007) Aspiration in chemoradiated patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 133:1289–1295PubMedCrossRef Langerman A, MacCracken E, Kasza K, Haraf DJ, Vokes EE, Stenson KM (2007) Aspiration in chemoradiated patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 133:1289–1295PubMedCrossRef
105.
go back to reference Hilgers FJ, Ackerstaff AH (2000) Comprehensive rehabilitation after total laryngectomy is more than voice alone. Folia Phoniatr Logop 52:65–73PubMedCrossRef Hilgers FJ, Ackerstaff AH (2000) Comprehensive rehabilitation after total laryngectomy is more than voice alone. Folia Phoniatr Logop 52:65–73PubMedCrossRef
106.
go back to reference Buchbinder D, Currivan RB, Kaplan AJ, Urken ML (1993) Mobilization regimens for the prevention of jaw hypomobility in the radiated patient: a comparison of three techniques. J Oral Maxillofac Surg 51:863–867PubMedCrossRef Buchbinder D, Currivan RB, Kaplan AJ, Urken ML (1993) Mobilization regimens for the prevention of jaw hypomobility in the radiated patient: a comparison of three techniques. J Oral Maxillofac Surg 51:863–867PubMedCrossRef
Metadata
Title
Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review
Authors
Lisette van der Molen
Maya A. van Rossum
Lori M. Burkhead
Ludi E. Smeele
Frans J. M. Hilgers
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 6/2009
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-008-0817-3

Other articles of this Issue 6/2009

European Archives of Oto-Rhino-Laryngology 6/2009 Go to the issue